Puracap Laboratories LLC

Greenvale, NY Doing business as BLU Pharmaceuticals Part of BLU Pharmaceuticals Corp

UEI
CMJ7J1HLH9N4
CAGE
4JB85
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
Corporate family
SAM.gov registration date
Physical address
87 Glen Cove Rd #3A, Greenvale, NY 11548, USA
Website
blurx.us
Founded
2008
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract vehicles

Contract awards

Award Agency Obligated Awarded
Doxycycline hyclate 75P00221F80028 Office of the Assistant Secretary for Administration $72,900
Pharmaceuticals 15F06718F0000948 Headquarters Division (FBI) $155,625
Doxycycline 100MG in 20 count bottles case packed 24 per case DJF171200C0001900 Headquarters Division (FBI) $155,625
Ciprofloxacin 500MG 20 count bottles DJF171200P0005871 Headquarters Division (FBI) $22,200

Similar vendors

About the company

Puracap Laboratories LLC, doing business as BLU Pharmaceuticals, is a for-profit limited liability company that manufactures and distributes pharmaceuticals. Through past federal contract awards, Puracap Laboratories has provided generic prescription medications including antibiotics, statins, and other drugs to support the healthcare requirements of various federal agencies and their beneficiaries.

Specifically, Puracap Laboratories has received federal contract awards to supply doxycycline hyclate tablets, simvastatin tablets, and azithromycin suspension. These contracts were primarily awarded by the Defense Logistics Agency, Department of Veterans Affairs, and Department of Health and Human Services to provide medications on an as-needed basis through the DLA/VA pharmaceutical prime vendor programs. Additionally, Puracap Laboratories holds multiple indefinite delivery vehicles to supply pharmaceuticals over one to five year periods, with potential values ranging from $1 million to $97 million. These include single-award IDCs from the Defense Logistics Agency and VA National Acquisition Center for manufacturing and distributing doxycycline, azithromycin, and simvastatin to the DoD, VA, Bureau of Prisons, and Indian Health Service. Puracap also holds a multiple award Federal Supply Schedule contract under the VA's Pharmaceuticals and Drugs schedule to provide various pharmaceuticals to VA health networks.

Across its portfolio of IDVs and orders, Puracap Laboratories supplies key medications central to public health missions. By repeatedly turning to this manufacturer over multiple contract vehicles, agencies like the VA, DLA and HHS demonstrate confidence in Puracap's capabilities supporting federal health programs through proven, streamlined contracting mechanisms designed to procure commercial pharmaceuticals efficiently.

Quick answers

Is Puracap Laboratories LLC registered in SAM.gov?

Yes. Puracap Laboratories LLC's SAM.gov registration is active through August 7, 2027.

Which contract vehicles does Puracap Laboratories LLC hold?

Puracap Laboratories LLC holds a place on 1 federal contract vehicle: FSS-61-IB.

What is Puracap Laboratories LLC's most recent federal award?

Puracap Laboratories LLC's most recent federal contract award is Doxycycline hyclate (75P00221F80028), from Office of the Assistant Secretary for Administration, on May 25, 2021.

On GovTribe

See Puracap Laboratories LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors